① 只持有智飞生物(300122)的收益为:69.81%
② (300122 vs 002156)按1:1配对交易,对冲风险组合收益为:112.61%
③ (300122 vs 002185)按1:1配对交易,对冲风险组合收益为:102.78%
④ (300122 vs 600359)按1:1配对交易,对冲风险组合收益为:78.45%
⑤ (300122 vs 600416)按1:1配对交易,对冲风险组合收益为:72.94%
⑥ (300122 vs 600289)按1:1配对交易,对冲风险组合收益为:72.63%
⑦ (300122 vs 002684)按1:1配对交易,对冲风险组合收益为:63.31%
⑧ (300122 vs 600371)按1:1配对交易,对冲风险组合收益为:63.23%
⑨ (300122 vs 300315)按1:1配对交易,对冲风险组合收益为:59.31%
ⓐ (300122 vs 600628)按1:1配对交易,对冲风险组合收益为:57.65%
ⓑ (300122 vs 300706)按1:1配对交易,对冲风险组合收益为:43.64%